Clinical trial
Comparative Effectiveness of Positive Airway Pressure Therapy, Dental Device, and Atomoxetine-Oxybutynin for Sleep Apnea: the ADAPT-OSA Study
NCT07679282 is registered in ClinicalTrials.gov with Sairam Parthasarathy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Effectiveness of Positive Airway Pressure Therapy, Dental Device, and Atomoxetine-Oxybutynin for Sleep Apnea: the ADAPT-OSA Study
- Lead sponsor
- Sairam Parthasarathy
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 4, 2026
- Completion date
- May 1, 2032
- Enrollment
- 2,400 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea (osa)